Bright Minds Biosciences (DRUG) Other Non Operating Income (2020 - 2026)

Bright Minds Biosciences has reported Other Non Operating Income for 7 years, with the latest figure at -$1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 2208.38% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at $737804.7 (up 165.65% YoY), and the FY2025 full-year result was $137165.4, up 2109.4% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$1.6 million, down from $1.1 million in the prior quarter.
• The five-year high for Other Non Operating Income was $1.9 million in Q2 2025, with the low at -$1.6 million in Q1 2026.
• Historically, Other Non Operating Income has averaged -$14644.9 across 5 years, with a median of $8057.4 in 2022.
• Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 10882.44% — and 2025, when it surged 13247.08%.
• Bright Minds Biosciences' Other Non Operating Income stood at $27356.7 in 2022, then slumped by 60.45% to $10820.4 in 2023, then slumped by 10882.44% to -$1.2 million in 2024, then surged by 190.93% to $1.1 million in 2025, then tumbled by 249.14% to -$1.6 million in 2026.
• The last three Other Non Operating Income figures came in at -$1.6 million (Q1 2026), $1.1 million (Q4 2025), and -$675577.3 (Q3 2025), per Business Quant data.